OFFICIAL PUBLICATION OF

pdl.com.au

by its subsidiary APPco

New Hepatitis C treatment TGA registered

Megan Haggan 06/09/2016

Hepatitis Virus - 3D Render

The TGA has registered a new treatment regimen for the treatment of chronic Hepatitis C.MSD announced that Zepatier (elbasvir/grazoprevir) with or without ribavirin has been registered by the TGA for the treatment of chronic hepatitis C virus genotype 1 and 4 infection in adults.The regimen is a once-daily tablet taken for 12 weeks, and is

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Teal questions pharmacist UTI programs

because much of the time, I think they’re giving antibiotics for things that are not UTIsPolitician says "I think" and…

Michael Hewson

Medics to ‘fight’ Doctor of Pharmacy title

Yet right now there are far too many reports from overseas of patients being unsure whether their care is from…

Michael Hewson

In scarce supply

I love a good joke.

Evan Nickols

Concurrent funding for aged care pharmacists and RMMRs needed

I understood that was to happen as a gradual changeover and not an abrupt cessation. Currently we do not have…

Jenny Gowan